Clinically, BC can be mainly divided into four different molecular subtypes according to the status of estrogen receptor (ER), progesterone receptor (PR), and HER2, including luminal A, luminal B, HER2-enriched, and basal-like [2, 3]. This evidence concerns the gene ESR1 and breast cancer.